- call +1-201-465-4211
- email sales@mrinsights.biz
Microneedle drug delivery systems usually include hollow microneedle and solid microneedle technology, offer patient-friendly delivery solutions for vaccines or difficult-to-deliver biologics for particularly needle-phobic patients.
Intradermal drug delivery is increasingly recognized as a potential solution to many of the challenges faced by new and existing medicines. Intradermal dosing provides the opportunity to more effectively administer agents such as small molecules, biologics, and vaccines, allowing for improved bioavailability. Nonetheless, the widespread use of this route of administration continues to be limited by technical challenges in the performing of intradermal injections, which requires specialized training and has poor reproducibility.
Microneedles are a rapidly growing technology developed to solve issues surrounding intradermal drug administration. While many microneedle platforms have been developed over nearly 2 decades, the issues and concerns remain largely the same.
According to this study, over the next five years the Microneedle Drug Delivery Systems market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Microneedle Drug Delivery Systems business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Microneedle Drug Delivery Systems market by product type, application, key companies and key regions.
This study considers the Microneedle Drug Delivery Systems value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Hollow Microneedle Technology
Solid Microneedle Technology
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Drug Delivery
Vaccine Delivery
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
3M
Zosano Pharma
Becton-Dickinson（BD）Technologies
Nanopass Technologies
Corium
Valeritas
Nitto
Microdermics
TheraJect
Vaxxas
Lohmann Therapie-Systeme AG
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Microneedle Drug Delivery Systems market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Microneedle Drug Delivery Systems market by identifying its various subsegments.
Focuses on the key global Microneedle Drug Delivery Systems players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Microneedle Drug Delivery Systems with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Microneedle Drug Delivery Systems submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
2019-2024 Global Microneedle Drug Delivery Systems Market Report (Status and Outlook)
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Microneedle Drug Delivery Systems Market Size 2014-2024
2.1.2 Microneedle Drug Delivery Systems Market Size CAGR by Region
2.2 Microneedle Drug Delivery Systems Segment by Type
2.2.1 Hollow Microneedle Technology
2.2.2 Solid Microneedle Technology
2.2.3 Dissolving Microneedles Technology
2.3 Microneedle Drug Delivery Systems Market Size by Type
2.3.1 Global Microneedle Drug Delivery Systems Market Size Market Share by Type (2014-2019)
2.3.2 Global Microneedle Drug Delivery Systems Market Size Growth Rate by Type (2014-2019)
2.4 Microneedle Drug Delivery Systems Segment by Application
2.4.1 Drug Delivery
2.4.2 Vaccine Delivery
2.4.3 Other
2.5 Microneedle Drug Delivery Systems Market Size by Application
2.5.1 Global Microneedle Drug Delivery Systems Market Size Market Share by Application (2014-2019)
2.5.2 Global Microneedle Drug Delivery Systems Market Size Growth Rate by Application (2014-2019)
3 Global Microneedle Drug Delivery Systems by Players
3.1 Global Microneedle Drug Delivery Systems Market Size Market Share by Players
3.1.1 Global Microneedle Drug Delivery Systems Market Size by Players (2017-2019)
3.1.2 Global Microneedle Drug Delivery Systems Market Size Market Share by Players (2017-2019)
3.2 Global Microneedle Drug Delivery Systems Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Microneedle Drug Delivery Systems by Regions
4.1 Microneedle Drug Delivery Systems Market Size by Regions
4.2 Americas Microneedle Drug Delivery Systems Market Size Growth
4.3 APAC Microneedle Drug Delivery Systems Market Size Growth
4.4 Europe Microneedle Drug Delivery Systems Market Size Growth
4.5 Middle East & Africa Microneedle Drug Delivery Systems Market Size Growth
5 Americas
5.1 Americas Microneedle Drug Delivery Systems Market Size by Countries
5.2 Americas Microneedle Drug Delivery Systems Market Size by Type
5.3 Americas Microneedle Drug Delivery Systems Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Microneedle Drug Delivery Systems Market Size by Countries
6.2 APAC Microneedle Drug Delivery Systems Market Size by Type
6.3 APAC Microneedle Drug Delivery Systems Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Microneedle Drug Delivery Systems by Countries
7.2 Europe Microneedle Drug Delivery Systems Market Size by Type
7.3 Europe Microneedle Drug Delivery Systems Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Microneedle Drug Delivery Systems by Countries
8.2 Middle East & Africa Microneedle Drug Delivery Systems Market Size by Type
8.3 Middle East & Africa Microneedle Drug Delivery Systems Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Microneedle Drug Delivery Systems Market Forecast
10.1 Global Microneedle Drug Delivery Systems Market Size Forecast (2019-2024)
10.2 Global Microneedle Drug Delivery Systems Forecast by Regions
10.2.1 Global Microneedle Drug Delivery Systems Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Microneedle Drug Delivery Systems Forecast by Type
10.8 Global Microneedle Drug Delivery Systems Forecast by Application
11 Key Players Analysis
11.1 3M
11.1.1 Company Details
11.1.2 Microneedle Drug Delivery Systems Product Offered
11.1.3 3M Microneedle Drug Delivery Systems Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 3M News
11.2 Zosano Pharma
11.2.1 Company Details
11.2.2 Microneedle Drug Delivery Systems Product Offered
11.2.3 Zosano Pharma Microneedle Drug Delivery Systems Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 Zosano Pharma News
11.3 Becton-Dickinson（BD）Technologies
11.3.1 Company Details
11.3.2 Microneedle Drug Delivery Systems Product Offered
11.3.3 Becton-Dickinson（BD）Technologies Microneedle Drug Delivery Systems Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 Becton-Dickinson（BD）Technologies News
11.4 Nanopass Technologies
11.4.1 Company Details
11.4.2 Microneedle Drug Delivery Systems Product Offered
11.4.3 Nanopass Technologies Microneedle Drug Delivery Systems Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 Nanopass Technologies News
11.5 Corium
11.5.1 Company Details
11.5.2 Microneedle Drug Delivery Systems Product Offered
11.5.3 Corium Microneedle Drug Delivery Systems Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 Corium News
11.6 Valeritas
11.6.1 Company Details
11.6.2 Microneedle Drug Delivery Systems Product Offered
11.6.3 Valeritas Microneedle Drug Delivery Systems Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 Valeritas News
11.7 Nitto
11.7.1 Company Details
11.7.2 Microneedle Drug Delivery Systems Product Offered
11.7.3 Nitto Microneedle Drug Delivery Systems Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 Nitto News
11.8 Microdermics
11.8.1 Company Details
11.8.2 Microneedle Drug Delivery Systems Product Offered
11.8.3 Microdermics Microneedle Drug Delivery Systems Revenue, Gross Margin and Market Share (2017-2019)
11.8.4 Main Business Overview
11.8.5 Microdermics News
11.9 TheraJect
11.9.1 Company Details
11.9.2 Microneedle Drug Delivery Systems Product Offered
11.9.3 TheraJect Microneedle Drug Delivery Systems Revenue, Gross Margin and Market Share (2017-2019)
11.9.4 Main Business Overview
11.9.5 TheraJect News
11.10 Vaxxas
11.10.1 Company Details
11.10.2 Microneedle Drug Delivery Systems Product Offered
11.10.3 Vaxxas Microneedle Drug Delivery Systems Revenue, Gross Margin and Market Share (2017-2019)
11.10.4 Main Business Overview
11.10.5 Vaxxas News
11.11 Lohmann Therapie-Systeme AG
12 Research Findings and Conclusion
List of Tables and Figures
Table Product Specifications of Microneedle Drug Delivery Systems
Figure Microneedle Drug Delivery Systems Report Years Considered
Figure Market Research Method
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
